Ribociclib and Letrozole Treatment in Ovarian Cancer

Running, not enrolling · Phase 2

Conditions studied: Low Grade Serous Carcinoma

In brief

The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.

Key facts

Study ID
NCT03673124
Run by
Gynecologic Oncology Group
People needed
51
Starts
2019-05-20
Expected to finish
2026-12-31
Last updated by the study team
2025-12-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.